Neuland Laboratories Limited — Board Meeting, 05-08-2026: Outcome of Board Meeting
05-08-2026 | 04:03 pm
05-08-2026 | 04:03 pm
Neuland Labs' board met, approving Q1 consolidated net profit of ₹147.67 Cr on revenue of ₹641.58 Cr. They've greenlit a ₹40 Cr corporate guarantee for a Gland Pharma sterile API partnership & a ₹39.8 Cr capacity expansion at Unit 1.
No comments yet. Be the first to comment!
